Mode of administration of dulaglutide: implications for treatment adherence

Mode of administration of dulaglutide: implications for treatment adherence

Ambika Amblee1,2 1Department of Internal Medicine, Division of Endocrinology, John Stroger Hospital of Cook County, 2Rush University Medical Center, Chicago, IL, USA Background: Medication complexity/burden can be associated with nonadherence in patients with type 2 diabetes mellitus (T2DM). Patie...

Full description

Bibliographic Details
Main Author:	Amblee A
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-06-01
Series:	Patient Preference and Adherence
Subjects:	Dulaglutide Treatment adherence mode of administration patient treatment satisfaction.
Online Access:	https://www.dovepress.com/mode-of-administration-of-dulaglutide-implications-for-treatment-adher-peer-reviewed-article-PPA

Similar Items

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial
by: Takahiro Takase, et al.
Published: (2019-05-01)

An observational study evaluating effectiveness and therapeutic adherence in patients with Type 2 Diabetes initiating dulaglutide vs. subcutaneous semaglutide in Spain
by: Santiago Tofé, et al.
Published: (2021-03-01)

Advances in the treatment of type 2 diabetes: impact of dulaglutide
by: Thompson AM, et al.
Published: (2016-05-01)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
by: Torre E, et al.
Published: (2020-04-01)

Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial
by: Antonino Tuttolomondo, et al.
Published: (2021-01-01)

Exacerbation of atrial fibrillation related to dulaglutide use
by: Jayden Lee, et al.
Published: (2021-05-01)

Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
by: A. S. Pogorelova, et al.
Published: (2018-03-01)

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
by: Morillo Verdugo R, et al.
Published: (2019-02-01)

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
by: Kutoh Eiji, et al.
Published: (2019-07-01)

Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin
by: Hiroyuki Uchinuma, et al.
Published: (2020-05-01)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
by: Manige Konig, et al.
Published: (2021-09-01)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
by: Kai-Cheng Chang, et al.
Published: (2020-10-01)

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study
by: Li Xin Shi, et al.
Published: (2020-01-01)

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies
by: Shuichi Suzuki, et al.
Published: (2017-06-01)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
by: Marina V. Shestakova, et al.
Published: (2017-08-01)

Once weekly dulaglutide therapy in type 2 diabetic subjects, real-world evidence from a tertiary care diabetes center in India
by: Jasjeet S Wasir, et al.
Published: (2018-01-01)

Efficacy of dulaglutide: an evidence-based review of its potential indications
by: E. V. Biryukova, et al.
Published: (2021-05-01)

Achieving the composite end‐point of glycated hemoglobin <7.0% without weight gain or hypoglycemia with once‐weekly dulaglutide in Chinese patients with type 2 diabetes: A post‐hoc analysis
by: Xinhua Xiao, et al.
Published: (2020-05-01)

Adherence and treatment satisfaction in liver transplant recipients
by: Abdulkareem M Albekairy, et al.
Published: (2016-01-01)

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
by: S. Ghosal, et al.
Published: (2018-05-01)

Satisfaction with and adherence to warfarin treatment: A cross-sectional study among Sudanese patients
by: Tarig Yousif Mohamed Eltayeb, et al.
Published: (2017-07-01)

Adherence to hemodialysis treatment and some related factors in hemodialysis patients admitted in Shahrekord Hajar hospital
by: Leila Rafiee Vardanjani, et al.
Published: (2014-01-01)

Analysis of treatment satisfaction and adherence among patients with type 2 diabetes
by: M. F. Kalashnikova, et al.
Published: (2020-12-01)

Self-compassion and adherence to treatment in patients with cancer
by: Neda Khalili, et al.
Published: (2021-01-01)

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
by: Lee J, et al.
Published: (2019-12-01)

Factors that affect adherence to recommended treatment among diabetes patients in Kampala
by: Fahlén, Elin, et al.
Published: (2016)

Adherence to treatment and related factors among patients with chronic conditions in primary care: a cross-sectional study
by: Cesar I. Fernandez-Lazaro, et al.
Published: (2019-09-01)

Treatment-related decisional conflict in patients with depressive and anxious disorders
by: De las Cuevas C, et al.
Published: (2016-06-01)

Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study
by: Fujikawa, J., et al.
Published: (2022)

OSTEOPOROSIS TREATMENT ADHERENCE: RESULTS FROM A RETROSPECTIVE COHORT STUDY
by: O. A. Nikitinskaya, et al.
Published: (2019-09-01)

Understanding Non-Adherence to Treatment in Hypertension: A Qualitative Study
by: Mahnaz Ashoorkhani, et al.
Published: (2018-10-01)

Problem of treatment adherence in tuberculosis patients
by: A. V. Belostotsky, et al.
Published: (2015-04-01)

Treatment Adherence in Adolescents with Asthma
by: Kaplan A, et al.
Published: (2020-01-01)

Factors related to reduced adherence to TB treatment in Keetmanshoop Namibia
by: Chinyama, Amos
Published: (2018)

Addressing the elephant in the room: a possible new way to increase patient adherence to medical advice
by: Grønhaug G
Published: (2017-06-01)

Adherence to <it>Plasmodium vivax </it>malaria treatment in the Brazilian Amazon Region
by: Pereira Elza A, et al.
Published: (2011-12-01)

Exploration of factors that influence poor adherence to antiretroviral therapy amongst patients at Pule Sefatsa primary health care clinic in Mangaung district, South Africa.
by: Jankie, Thenjiwe Rose
Published: (2019)

Determinants of adherence to tuberculosis therapy among patients receiving Directly Observed Treatment from a district hospital in Pretoria, South Africa
by: Aiyegoro, Olayinka Ayobami
Published: (2017)

Adherence to treatment guidelines in a university hospital: Exploration of facts and factors
by: Swarmita Afreen, et al.
Published: (2014-04-01)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
by: Maria Mirabelli, et al.
Published: (2021-03-01)